🇪🇺 SACITUZUMAB GOVITECAN in European Union

SACITUZUMAB GOVITECAN (SACITUZUMAB GOVITECAN) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/005182
  • Local brand name: Trodelvy
  • Status: approved

SACITUZUMAB GOVITECAN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is SACITUZUMAB GOVITECAN approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for SACITUZUMAB GOVITECAN in European Union?

Marketing authorisation holder not available in our data.